Computational platform Way2Drug: from the prediction of biological activity to drug repurposing


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

The Way2Drug informational-computational platform (www.way2drug.com/dr) provides access to the data on drugs approved for medicinal use in the USA and Russian Federation, as well as computational possibilities for the prediction of biological activity of drug-like organic compounds. Currently realized computational tools of the platform, which allow one to predict several thousands of biological activity types, including the interaction with molecular targets, pharmacotherapeutic and side effects, metabolism, acute toxicity for rats, cytotoxicity, influence on gene expression, and other properties characterizing the evaluation how promising are particular drug-like compounds as potential pharmaceuticals, are reviewed. Using the Way2Drug platform, one can not only select the most promising "hits" for the synthesis and testing of biological activity but also reveal new indications for the launched drugs.

Об авторах

D. Druzhilovskiy

Institute of Biomedical Chemistry

Автор, ответственный за переписку.
Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

A. Rudik

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

D. Filimonov

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

T. Gloriozova

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

A. Lagunin

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

A. Dmitriev

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

P. Pogodin

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

V. Dubovskaya

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

S. Ivanov

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

O. Tarasova

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

V. Bezhentsev

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

K. Murtazalieva

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

M. Semin

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

I. Maiorov

Institute of Biomedical Chemistry; N. I. Pirogov Russian National Research Medical University

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121; 1 ul. Ostrovityanova, Moscow, 117997

A. Gaur

CSIR-Indian Institute of Chemical Technology

Email: dmitry.druzhilovsky@ibmc.msk.ru
Индия, Hyderabad, 500 007

G. Sastry

CSIR-Indian Institute of Chemical Technology

Email: dmitry.druzhilovsky@ibmc.msk.ru
Индия, Hyderabad, 500 007

V. Poroikov

Institute of Biomedical Chemistry

Email: dmitry.druzhilovsky@ibmc.msk.ru
Россия, 10/8 Pogodinskaya ul., Moscow, 119121

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2017

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).